Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine, advance its pipeline, and expand its headcount in its first external funding ...

The device's enduring reliability equates to millions of sales each year for Japan's Casio, which is even eyeing expansion in certain regions. Despite lightning-speed advances in artificial ...

For 30 years, the technology that could help save the world has been in the hands of children. Solar calculators were such a routine part of math class from the mid-1980s onward that they barely ...

Until now, cells dividing by mitosis were thought to grow round and then split into two identical, spherical daughter cells. New research has found that some cells are isomorphic, meaning they retain ...

Stream NBC 5 for free, 24/7, wherever you are. On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck.

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

March 31 (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the ...

Isomorphic Labs was spun out of DeepMind in 2021 as a commercial venture, aiming to 'reimagine' the entire drug discovery process Isomorphic Labs, a subsidiary of Google parent Alphabet that uses ...

Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs and Google DeepMind. According to ...

Isomorphic Labs was established by Alphabet in 2021, as a spin-off from DeepMind, an AI startup that Alphabet acquired in 2014. Demis Hassabis, the leader of DeepMind and the individual in charge of ...

Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas. The 4-year-old subsidiary of Google ...